Skip to main content
NCBI home page
Gut logoLink to Gut
. 1998 Nov;43(5):705–710. doi: 10.1136/gut.43.5.705

Fatigue in primary biliary cirrhosis

K Cauch-Dudek 1, S Abbey 1, D Stewart 1, E Heathcote 1
PMCID: PMC1727314  PMID: 9824355

Abstract

Background—Fatigue is a frequent and debilitating symptom in patients with primary biliary cirrhosis (PBC). 
Aims—To study fatigue in relation to sleep, depression, and liver disease severity. 
Methods—Patients with PBC completed validated self report questionnaires measuring fatigue, sleep quality, depression, and functional capacity. Verbally reported fatigue and observer rated measure of depression and ursodeoxycholic acid (UDCA) use were recorded. Liver biochemistry and tests to rule out metabolic causes of fatigue were performed. 
Results—Mean age of the 88 patients enrolled was 57 years; 86% were female and mean duration of disease was 6.6 years. Median bilirubin was 13 µmol/l (mean 18.6). Verbally reported fatigue (for more than six months) was present in 60 patients (68%). The self rated Fatigue Severity Score (FSS) correlated well with verbally reported fatigue (p=0.0001). The FSS did not correlate with age, duration of disease, serum bilirubin, Mayo Risk Score, or UDCA use, but correlation was seen with sleep quality. Fatigued patients had more sleep problems and higher depression scores than non-fatigued patients. Self rated depression was present in 28% (17/60) of fatigued compared with 4% (1/28) of non-fatigued patients. 
Conclusions—Long term fatigue affected 68% of the patients with PBC but it was not related to the severity of their liver disease. Poor sleep quality and depression were commonly associated with fatigue. 



Keywords: primary biliary cirrhosis; fatigue; depression; sleep

Full Text

The Full Text of this article is available as a PDF (140.7 KB).

Figure 1 .

Figure 1

Open in a new tab

Fatigue Severity Scale score versus total serum bilirubin and Mayo Risk Score. There is some overlap of points within the figure. 


Figure 2 .

Figure 2

Open in a new tab

Comparison of sleep in patients with and without verbally reported fatigue and a normal control population. 


Figure 3 .

Figure 3

Open in a new tab

Fatigue Severity Scale score versus global sleep quality. The PSQI global score range for normal controls is 0-2.67.11 There is some overlap of points within the figure. 


Figure 4 .

Figure 4

Open in a new tab

Fatigue Severity Scale score versus depression. There is some overlap of points within the figure. 


Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barofsky I., Legro M. W. Definition and measurement of fatigue. Rev Infect Dis. 1991 Jan-Feb;13 (Suppl 1):S94–S97. doi: 10.1093/clinids/13.supplement_1.s94. [DOI] [PubMed] [Google Scholar]
  2. Buysse D. J., Reynolds C. F., 3rd, Monk T. H., Berman S. R., Kupfer D. J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193–213. doi: 10.1016/0165-1781(89)90047-4. [DOI] [PubMed] [Google Scholar]
  3. Cardenas D. D., Kutner N. G. The problem of fatigue in dialysis patients. Nephron. 1982;30(4):336–340. doi: 10.1159/000182512. [DOI] [PubMed] [Google Scholar]
  4. Cathébras P. J., Robbins J. M., Kirmayer L. J., Hayton B. C. Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome. J Gen Intern Med. 1992 May-Jun;7(3):276–286. doi: 10.1007/BF02598083. [DOI] [PubMed] [Google Scholar]
  5. Chen M. K. The epidemiology of self-perceived fatigue among adults. Prev Med. 1986 Jan;15(1):74–81. doi: 10.1016/0091-7435(86)90037-x. [DOI] [PubMed] [Google Scholar]
  6. Dickson E. R., Grambsch P. M., Fleming T. R., Fisher L. D., Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology. 1989 Jul;10(1):1–7. doi: 10.1002/hep.1840100102. [DOI] [PubMed] [Google Scholar]
  7. Endicott J., Cohen J., Nee J., Fleiss J., Sarantakos S. Hamilton Depression Rating Scale. Extracted from Regular and Change Versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1981 Jan;38(1):98–103. doi: 10.1001/archpsyc.1981.01780260100011. [DOI] [PubMed] [Google Scholar]
  8. Fobair P., Hoppe R. T., Bloom J., Cox R., Varghese A., Spiegel D. Psychosocial problems among survivors of Hodgkin's disease. J Clin Oncol. 1986 May;4(5):805–814. doi: 10.1200/JCO.1986.4.5.805. [DOI] [PubMed] [Google Scholar]
  9. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  10. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Heathcote E. J., Cauch-Dudek K., Walker V., Bailey R. J., Blendis L. M., Ghent C. N., Michieletti P., Minuk G. Y., Pappas S. C., Scully L. J. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 1994 May;19(5):1149–1156. [PubMed] [Google Scholar]
  12. Jones E. A. Fatigue associated with chronic liver disease: a riddle wrapped in a mystery inside an enigma. Hepatology. 1995 Nov;22(5):1606–1608. [PubMed] [Google Scholar]
  13. Krupp L. B., LaRocca N. G., Muir-Nash J., Steinberg A. D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 Oct;46(10):1121–1123. doi: 10.1001/archneur.1989.00520460115022. [DOI] [PubMed] [Google Scholar]
  14. Krupp L. B., LaRocca N. G., Muir-Nash J., Steinberg A. D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 Oct;46(10):1121–1123. doi: 10.1001/archneur.1989.00520460115022. [DOI] [PubMed] [Google Scholar]
  15. Krupp L. B., LaRocca N. G., Muir J., Steinberg A. D. A study of fatigue in systemic lupus erythematosus. J Rheumatol. 1990 Nov;17(11):1450–1452. [PubMed] [Google Scholar]
  16. Lindor K. D., Dickson E. R., Baldus W. P., Jorgensen R. A., Ludwig J., Murtaugh P. A., Harrison J. M., Wiesner R. H., Anderson M. L., Lange S. M. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology. 1994 May;106(5):1284–1290. doi: 10.1016/0016-5085(94)90021-3. [DOI] [PubMed] [Google Scholar]
  17. Lindor K. D., Therneau T. M., Jorgensen R. A., Malinchoc M., Dickson E. R. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology. 1996 May;110(5):1515–1518. doi: 10.1053/gast.1996.v110.pm8613058. [DOI] [PubMed] [Google Scholar]
  18. McKinley P. S., Ouellette S. C., Winkel G. H. The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model. Arthritis Rheum. 1995 Jun;38(6):826–834. doi: 10.1002/art.1780380617. [DOI] [PubMed] [Google Scholar]
  19. Merican I., Sherlock S., McIntyre N., Dusheiko G. M. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Q J Med. 1993 Feb;86(2):119–125. [PubMed] [Google Scholar]
  20. Myers J. K., Weissman M. M., Tischler G. L., Holzer C. E., 3rd, Leaf P. J., Orvaschel H., Anthony J. C., Boyd J. H., Burke J. D., Jr, Kramer M. Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry. 1984 Oct;41(10):959–967. doi: 10.1001/archpsyc.1984.01790210041006. [DOI] [PubMed] [Google Scholar]
  21. Offord D. R., Boyle M. H., Campbell D., Goering P., Lin E., Wong M., Racine Y. A. One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry. 1996 Nov;41(9):559–563. doi: 10.1177/070674379604100904. [DOI] [PubMed] [Google Scholar]
  22. Pawlikowska T., Chalder T., Hirsch S. R., Wallace P., Wright D. J., Wessely S. C. Population based study of fatigue and psychological distress. BMJ. 1994 Mar 19;308(6931):763–766. doi: 10.1136/bmj.308.6931.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Poupon R. E., Balkau B., Eschwège E., Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med. 1991 May 30;324(22):1548–1554. doi: 10.1056/NEJM199105303242204. [DOI] [PubMed] [Google Scholar]
  24. Poupon R. E., Lindor K. D., Cauch-Dudek K., Dickson E. R., Poupon R., Heathcote E. J. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology. 1997 Sep;113(3):884–890. doi: 10.1016/s0016-5085(97)70183-5. [DOI] [PubMed] [Google Scholar]
  25. Robins L. N., Helzer J. E., Weissman M. M., Orvaschel H., Gruenberg E., Burke J. D., Jr, Regier D. A. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984 Oct;41(10):949–958. doi: 10.1001/archpsyc.1984.01790210031005. [DOI] [PubMed] [Google Scholar]
  26. Schwartz J. E., Jandorf L., Krupp L. B. The measurement of fatigue: a new instrument. J Psychosom Res. 1993 Oct;37(7):753–762. doi: 10.1016/0022-3999(93)90104-n. [DOI] [PubMed] [Google Scholar]
  27. Swain M. G., Maric M. Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviors. Hepatology. 1995 Nov;22(5):1560–1564. [PubMed] [Google Scholar]
  28. Walker E. A., Katon W. J., Jemelka R. P. Psychiatric disorders and medical care utilization among people in the general population who report fatigue. J Gen Intern Med. 1993 Aug;8(8):436–440. doi: 10.1007/BF02599621. [DOI] [PubMed] [Google Scholar]
  29. Wessely S. The epidemiology of chronic fatigue syndrome. Epidemiol Rev. 1995;17(1):139–151. doi: 10.1093/oxfordjournals.epirev.a036170. [DOI] [PubMed] [Google Scholar]
  30. Witt-Sullivan H., Heathcote J., Cauch K., Blendis L., Ghent C., Katz A., Milner R., Pappas S. C., Rankin J., Wanless I. R. The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology. 1990 Jul;12(1):98–105. doi: 10.1002/hep.1840120116. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES